These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 36835590)

  • 1. Serum Biomarkers in Connective Tissue Disease-Associated Pulmonary Arterial Hypertension.
    Moccaldi B; De Michieli L; Binda M; Famoso G; Depascale R; Perazzolo Marra M; Doria A; Zanatta E
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment strategies and survival of patients with connective tissue disease and pulmonary arterial hypertension: a COMPERA analysis.
    Distler O; Ofner C; Huscher D; Jordan S; Ulrich S; Stähler G; Grünig E; Held M; Ghofrani HA; Claussen M; Lange TJ; Klose H; Rosenkranz S; Vonk-Noordegraaf A; Vizza CD; Delcroix M; Opitz C; Pausch C; Scelsi L; Neurohr C; Olsson KM; Coghlan JG; Halank M; Skowasch D; Behr J; Milger K; Remppis BA; Skride A; Jureviciene E; Gumbiene L; Miliauskas S; Löffler-Ragg J; Wilkens H; Pittrow D; Hoeper MM; Ewert R
    Rheumatology (Oxford); 2024 Apr; 63(4):1139-1146. PubMed ID: 37462520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary hypertension in connective tissue diseases: epidemiology, pathogenesis, and treatment.
    Cansu DÜ; Korkmaz C
    Clin Rheumatol; 2023 Oct; 42(10):2601-2610. PubMed ID: 36396789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recommendations for screening and detection of connective tissue disease-associated pulmonary arterial hypertension.
    Khanna D; Gladue H; Channick R; Chung L; Distler O; Furst DE; Hachulla E; Humbert M; Langleben D; Mathai SC; Saggar R; Visovatti S; Altorok N; Townsend W; FitzGerald J; McLaughlin VV;
    Arthritis Rheum; 2013 Dec; 65(12):3194-201. PubMed ID: 24022584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Idiopathic and connective tissue disease-associated pulmonary arterial hypertension (PAH): Similarities, differences and the role of autoimmunity.
    Favoino E; Prete M; Liakouli V; Leone P; Sisto A; Navarini L; Vomero M; Ciccia F; Ruscitti P; Racanelli V; Giacomelli R; Perosa F
    Autoimmun Rev; 2024 Apr; 23(4):103514. PubMed ID: 38181859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Recommendations for the diagnosis and treatment of connective tissue disease associated pulmonary arterial hypertension in China].
    Zhang X; Zhao JL; Ding F; Yang J; Wang J; Zeng XF; Zhao Y
    Zhonghua Nei Ke Za Zhi; 2022 Nov; 61(11):1206-1216. PubMed ID: 36323561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The treatment strategy of connective tissue disease associated pulmonary arterial hypertension: Evolving into the future.
    Zhao J; Wang Q; Deng X; Qian J; Tian Z; Liu Y; Li M; Zeng X
    Pharmacol Ther; 2022 Nov; 239():108192. PubMed ID: 35461923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of pulmonary arterial pressure in patients with connective tissue disease-associated pulmonary arterial hypertension by myocardial perfusion imaging.
    Wang Z; Li J; Wang X; Liu M; Liao M; Zhang C; Shang X
    Ann Noninvasive Electrocardiol; 2022 Mar; 27(2):e12927. PubMed ID: 34908208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dendritic Cell Subsets and Effector Function in Idiopathic and Connective Tissue Disease-Associated Pulmonary Arterial Hypertension.
    van Uden D; Boomars K; Kool M
    Front Immunol; 2019; 10():11. PubMed ID: 30723471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary Arterial Hypertension in Connective Tissue Diseases Beyond Systemic Sclerosis.
    Lewis C; Sanderson R; Vasilottos N; Zheutlin A; Visovatti S
    Heart Fail Clin; 2023 Jan; 19(1):45-54. PubMed ID: 36435572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary arterial hypertension associated with connective tissue diseases (CTD-PAH): Recent and advanced data.
    Thoreau B; Mouthon L
    Autoimmun Rev; 2024 Apr; 23(4):103506. PubMed ID: 38135175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 10-year survival of pulmonary arterial hypertension associated with connective tissue disease: insights from a multicentre PAH registry.
    Chen X; Quan R; Qian Y; Yang Z; Yu Z; Zhang C; Yang Y; Zhang G; Shen J; Wang Q; Gu Q; Xiong C; Jing X; Han H; He J
    Rheumatology (Oxford); 2023 Nov; 62(11):3555-3564. PubMed ID: 36912696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating markers of inflammation and angiogenesis and clinical outcomes across subtypes of pulmonary arterial hypertension.
    Hirsch K; Nolley S; Ralph DD; Zheng Y; Altemeier WA; Rhodes CJ; Morrell NW; Wilkins MR; Leary PJ; Rayner SG
    J Heart Lung Transplant; 2023 Feb; 42(2):173-182. PubMed ID: 36470771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolomic Differences in Connective Tissue Disease-Associated Versus Idiopathic Pulmonary Arterial Hypertension in the PVDOMICS Cohort.
    Simpson CE; Hemnes AR; Griffiths M; Grunig G; Tang WHW; Garcia JGN; Barnard J; Comhair SA; Damico RL; Mathai SC; Hassoun PM;
    Arthritis Rheumatol; 2023 Dec; 75(12):2240-2251. PubMed ID: 37335853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [2020 Chinese expert-based consensus statement regarding the diagnosis and treatment of connective tissue disease associated pulmonary arterial hypertension].
    ; ;
    Zhonghua Nei Ke Za Zhi; 2021 May; 60(5):406-420. PubMed ID: 33906271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of pulmonary arterial hypertension in connective tissue disease.
    Grünig E
    Drugs; 2012 May; 72(8):1039-56. PubMed ID: 22621693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological management of connective tissue disease-associated pulmonary arterial hypertension.
    Kularatne M; Boucly A; Savale L; Solinas S; Cheron C; Roche A; Jevnikar M; Jaïs X; Montani D; Humbert M; Sitbon O
    Expert Opin Pharmacother; 2023; 24(18):2101-2115. PubMed ID: 37869785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical analysis of pulmonary arterial hypertension secondary to connective tissue disease in children].
    Xing Y; Song HM; Wu XY; He YY; Wei M
    Zhonghua Er Ke Za Zhi; 2008 Nov; 46(11):822-6. PubMed ID: 19099898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-World Treatment Patterns Among Patients with Connective Tissue Disorder-Related Pulmonary Arterial Hypertension in the United States: A Retrospective Claims-Based Analysis.
    Sargent T; Tsang Y; Panjabi S; Funtanilla V; Germack HD; Gauthier-Loiselle M; Manceur AM; Cloutier M; Lefebvre P
    Adv Ther; 2023 Nov; 40(11):5037-5054. PubMed ID: 37728697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum uric acid is associated with disease severity and may predict clinical outcome in patients of pulmonary arterial hypertension secondary to connective tissue disease in Chinese: a single-center retrospective study.
    Wang J; Wang Y; Li X; Huang Y; Sun X; Wang Q; Zhang M
    BMC Pulm Med; 2020 Oct; 20(1):272. PubMed ID: 33076877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.